Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 48, 7273-7278, December 1, 1988]
© 1988 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Starling, J. J.
Right arrow Articles by Johnson, D. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Starling, J. J.
Right arrow Articles by Johnson, D. A.

Tissue Distribution and Cellular Location of the Antigens Recognized by Human Monoclonal Antibodies 16.88 and 28A32

James J. Starling1, Richard J. Cote, Philip Marder, Michael J. Borowitz and David A. Johnson

Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana 46285 [J. J. S., P. M., D. A. J.]; Department of Human Tumor Immunology and Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021 [R. J. C.]; and Department of Pathology, Duke University, Durham, North Carolina 27710 [M. J. B.]

Results from a previous study (M. V. Haspel et al., Cancer Res., 45: 3951–3961, 1985) indicated that it was possible to isolate a high proportion of human monoclonal antibodies reactive with cell surface, tumorassociated antigens when the hybridomas were obtained from fusions utilizing peripheral blood lymphocytes from patients immunized with autologous tumor cells. The assignment of membrane reactivity was made from immunoperoxidase studies which used air-dried, nonpermeabilized Cytospin preparations of colon tumor cells. Tumor specificity was assessed by immunohistological assays by using frozen sections of normal and malignant human tissues. We now describe a series of studies using two of these antibodies, 16.88 and 28A32, in which further information was obtained concerning the tumor specificity and cellular location of the target antigens reactive with these monoclonal antibodies. Data were acquired from a variety of experimental techniques which included quantitative and qualitative immunofluorescence on live and permeabilized cells, RBC-rosetting assays, immunoperoxidase studies on Cytospin and frozen tissue sections, and immunoblot procedures. These studies show that the 16.88 and 28A32 human monoclonal antibodies bind to antigens which (a) are located in the cell cytoplasm and are not expressed in detectable levels on the cell surface, and (b) are found in many normal and malignant cell types.

1 To whom requests for reprints should be addressed, at Lilly Research Laboratories, Department MC620, Building 98C/4, Lilly Corporate Center, Indianapolis, IN 46285.

Received 6/10/88. Revised 8/30/88. Accepted 9/ 8/88.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1988 by the American Association for Cancer Research.